Evidence map›Paper›PMID 42810763›Full record

ArticleBMJ open quality2026

Implementation of self-collected cervical screening in an under-screened, culturally and linguistically diverse antenatal population: a quality improvement study.

Mandy Wang, Alison Brand, Martin Plymoth, Judy Chen, Therese McGee

Abstract read
In one paragraph

Article in BMJ open quality, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mandy WangThe University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia mandymw100@gmail.com.ORCID http://orcid.org/0000-0002-6509-6926
Alison BrandThe University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia.
Martin PlymothWestmead Hospital Women's & Newborn Health Department, Westmead, New South Wales, Australia.
Judy ChenWestmead Hospital Women's & Newborn Health Department, Westmead, New South Wales, Australia.
Therese McGeeThe University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Eliminating cervical cancer requires high screening participation levels. Pregnancy is an opportunity to reach under-screened women, but clinician-collected speculum examination is a barrier to uptake. Patient self-collected cervical screening tests (SC-CST) using a vaginal swab for detection of human papillomavirus (HPV) may offer a solution. The objective of this study was to evaluate the outcomes and implementation of a comprehensive programme embedding SC-CST into antenatal care.This is a prospective quality improvement study in a tertiary hospital servicing a population with one of the lowest cervical screening rates nationally. Pregnant women attending public maternity care and eligible for screening under national guidelines were included. Screening histories were obtained from the national registry to identify screen-overdue or never-screened women for SC-CST offer. Staff education and patient information encouraged participation. Test packs facilitated specimen collection. Referral pathways were created for abnormal results. Main outcome measures include reach, effectiveness, implementation and maintenance of quality improvement.From 19 February 2024 to 31 July 2025, 48.0% (2492/5190) of eligible pregnant women required a CST, 69.7% were offered SC-CST and 93.7% accepted. Cervical screening rates increased 22-fold from 3.0% prior to the programme to 65.3%. Parous women were offered SC-CST at lower rates than nulliparous women (66.5% vs 74.1%; p=0.024). Women residing in the lowest socioeconomic quintile had lower acceptance rates (91.9% vs 94.8%; p=0.024). Being overseas-born and need for interpreter were not barriers to SC-CST offer or acceptance rates. Results were high risk HPV-negative in 88.1%, HPV 16/18 positive in 1.9%, HPV non-16/18 positive in 9.1% and invalid in 0.9%. Colposcopy was performed for 41 women, with 7 cases of biopsy-confirmed high-grade squamous intraepithelial lesion requiring treatment.Introduction of SC-CST into antenatal care is an effective strategy to improve cervical screening rates and was highly acceptable to pregnant women. Programme sustainability requires additional resources, staff engagement, and timely follow-up.

Indexed as

Early Detection of CancerMass ScreeningSpecimen HandlingUterine Cervical NeoplasmsAdultFemaleHumansPapillomavirus InfectionsPregnancyPrenatal CareProspective StudiesQuality ImprovementHealthcare quality improvementImplementation scienceMaternal Health ServicesObstetrics and gynecologyWomen's health

Identifiers

PMID42810763
PMCPMC13630108

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.